O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 3.955 EUR -0.25% Market Closed
Market Cap: 76.2m EUR
Have any thoughts about
Optomed Oyj?
Write Note

Wall Street
Price Targets

OPTOMED Price Targets Summary
Optomed Oyj

Wall Street analysts forecast OPTOMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPTOMED is 5.738 EUR with a low forecast of 5.05 EUR and a high forecast of 7.35 EUR.

Lowest
Price Target
5.05 EUR
28% Upside
Average
Price Target
5.738 EUR
45% Upside
Highest
Price Target
7.35 EUR
86% Upside
Optomed Oyj Competitors:
Price Targets
SHL
Siemens Healthineers AG
21% Upside
EKF
EKF Diagnostics Holdings PLC
39% Upside
OFIX
Orthofix Medical Inc
32% Upside
300482
Guangzhou Wondfo Biotech Co Ltd
41% Upside
301367
BMC Medical Co Ltd
11% Upside
TMDX
Transmedics Group Inc
77% Upside
ZOM
Zomedica Corp
96% Upside
300529
Jafron Biomedical Co Ltd
45% Upside

Revenue
Forecast

Revenue Estimate
Optomed Oyj

For the last 4 years the compound annual growth rate for Optomed Oyj's revenue is 0%. The projected CAGR for the next 3 years is 29%.

0%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Optomed Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat

Net Income
Forecast

Net Income Estimate
Optomed Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPTOMED's stock price target?
Price Target
5.738 EUR

According to Wall Street analysts, the average 1-year price target for OPTOMED is 5.738 EUR with a low forecast of 5.05 EUR and a high forecast of 7.35 EUR.

What is Optomed Oyj's Revenue forecast?
Projected CAGR
29%

For the last 4 years the compound annual growth rate for Optomed Oyj's revenue is 0%. The projected CAGR for the next 3 years is 29%.

Back to Top